Despite being a common form of dementia, there is still a tremendous need for more physician education on Lewy body dementia (LBD). To address this issue, LBDA is proud to partner with Medscape on an educational activity designed for neurologists, primary care physicians, and psychiatrists. Although these physicians are best positioned to provide clinical care for those with LBD, all physicians may find this activity useful in their treatment of patients diagnosed with Lewy body dementia.
“An Introduction to Lewy body dementia” features renowned LBD experts James Galvin, MD from the University of Miami and Jennifer Goldman, MD from the Shirley Ryan AbilityLab and Northwestern University. Both are longtime members of LBDA’s Scientific Advisory Council and primary investigators for LBDA’s Research Centers of Excellence program.
The goal of the activity is to increase knowledge in diagnosis and treatment of LBD in clinical practice. Through a series of patient cases, learners will be able to discuss prevalence and pathophysiology of LBD; identify symptoms of LBD using appropriate assessment tools, determine a differential diagnosis and develop clinical management skills in treating patients with LBD.
The activity is designated for AMA PRA category 1 creditTM for up to 1 year on Medscape and was supported by an independent educational grant from ACADIA Pharmaceuticals.
To participate in the CME activity, click here.
*Please note, that you will be required to register prior to accessing the content.